10x Genomics reported quarterly EPS of -$0.10, beating the Zacks Consensus Estimate of a -$0.29 loss and improving from a -$0.36 loss a year ago. The result indicates a smaller-than-expected loss and year-over-year earnings improvement, which is supportive for near-term sentiment. The news is likely stock-specific rather than sector-wide.
10x Genomics reported quarterly EPS of -$0.10, beating the Zacks Consensus Estimate of a -$0.29 loss and improving from a -$0.36 loss a year ago. The result indicates a smaller-than-expected loss and year-over-year earnings improvement, which is supportive for near-term sentiment. The news is likely stock-specific rather than sector-wide.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
